219 related articles for article (PubMed ID: 33191354)
1. The Effect of Renin-Angiotensin System Inhibitors on the Recurrence of Atrial Fibrillation After Catheter Ablation.
Zhao J; Chen M; Zhuo C; Huang Y; Zheng L; Wang Q
Int Heart J; 2020 Nov; 61(6):1174-1182. PubMed ID: 33191354
[TBL] [Abstract][Full Text] [Related]
2. Renin-Angiotensin System Inhibitors for the Prevention of Atrial Fibrillation Recurrence After Ablation - A Meta-Analysis.
Peng L; Li Z; Luo Y; Tang X; Shui X; Xie X; Zheng Z; Dong R; Liu J; Zhu J; Li S
Circ J; 2020 Sep; 84(10):1709-1717. PubMed ID: 32879151
[TBL] [Abstract][Full Text] [Related]
3. Renin-angiotensin system inhibitors for prevention of recurrent atrial fibrillation: a meta-analysis.
Li TJ; Zang WD; Chen YL; Geng N; Ma SM; Li XD
Int J Clin Pract; 2013 Jun; 67(6):536-43. PubMed ID: 23557493
[TBL] [Abstract][Full Text] [Related]
4. The effect of statins on the recurrence rate of atrial fibrillation after catheter ablation: A meta-analysis.
Peng H; Yang Y; Zhao Y; Xiao H
Pacing Clin Electrophysiol; 2018 Nov; 41(11):1420-1427. PubMed ID: 30191566
[TBL] [Abstract][Full Text] [Related]
5. Impact of angiotensin-converting enzyme-inhibitors and angiotensin receptor blockers on long-term outcome of catheter ablation for atrial fibrillation.
Tayebjee MH; Creta A; Moder S; Hunter RJ; Earley MJ; Dhinoja MB; Schilling RJ
Europace; 2010 Nov; 12(11):1537-42. PubMed ID: 20682557
[TBL] [Abstract][Full Text] [Related]
6. The effects of statins and renin-angiotensin system blockers on atrial fibrillation recurrence following antral pulmonary vein isolation.
Al Chekakie MO; Akar JG; Wang F; Al Muradi H; Wu J; Santucci P; Varma N; Wilber DJ
J Cardiovasc Electrophysiol; 2007 Sep; 18(9):942-6. PubMed ID: 17593228
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers have no beneficial effect on ablation outcome in chronic persistent atrial fibrillation.
Zheng B; Kang J; Tian Y; Tang R; Long D; Yu R; He H; Zhang M; Shi L; Tao H; Liu X; Dong J; Ma C
Acta Cardiol; 2009 Jun; 64(3):335-40. PubMed ID: 19593943
[TBL] [Abstract][Full Text] [Related]
8. Renin-angiotensin system inhibition is associated with reduced risk of left atrial appendage thrombosis formation in patients with atrial fibrillation.
Suo Y; Zhang Y; Wang Y; Yuan M; Kariyawasam S; Tse G; Liu T; Fu H; Li G
Cardiol J; 2018; 25(5):611-620. PubMed ID: 28980280
[TBL] [Abstract][Full Text] [Related]
9. Effect of corticosteroids on atrial fibrillation after catheter ablation: a meta-analysis
Jaiswal S; Liu XB; Wei QC; Sun YH; Wang LH; Song LG; Yang DD; Wang JA
J Zhejiang Univ Sci B; 2018 Jan.; 19(1):57-64. PubMed ID: 29308608
[TBL] [Abstract][Full Text] [Related]
10. Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis.
Schneider MP; Hua TA; Böhm M; Wachtell K; Kjeldsen SE; Schmieder RE
J Am Coll Cardiol; 2010 May; 55(21):2299-307. PubMed ID: 20488299
[TBL] [Abstract][Full Text] [Related]
11. Therapy with renin-angiotensin system blockers after pulmonary vein isolation in patients with atrial fibrillation: who is a responder?
Berkowitsch A; Neumann T; Kuniss M; Janin S; Wojcik M; Zaltsberg S; Mitrovic V; Pitschner HF
Pacing Clin Electrophysiol; 2010 Sep; 33(9):1101-11. PubMed ID: 20487340
[TBL] [Abstract][Full Text] [Related]
12. [Unsatisfactory results of upstream therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for the prevention of recurrent atrial fibrillation].
Disertori M; Zeni P; Quintarelli S; Bonmassari R
G Ital Cardiol (Rome); 2010 Nov; 11(11):829-34. PubMed ID: 21348320
[TBL] [Abstract][Full Text] [Related]
13. Preventive effect of renin-angiotensin system inhibitors on new-onset atrial fibrillation in hypertensive patients: a propensity score matching analysis.
Horio T; Akiyama M; Iwashima Y; Yoshihara F; Nakamura S; Tokudome T; Okutsu M; Tanaka H; Komatsubara I; Okimoto N; Kamakura S; Kawano Y
J Hum Hypertens; 2017 Jul; 31(7):450-456. PubMed ID: 28032630
[TBL] [Abstract][Full Text] [Related]
14. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of Short-Term Antiarrhythmic Drugs Use after Catheter Ablation of Atrial Fibrillation-A Systematic Review with Meta-Analyses and Trial Sequential Analyses of Randomized Controlled Trials.
Chen W; Liu H; Ling Z; Xu Y; Fan J; Du H; Xiao P; Su L; Liu Z; Lan X; Zrenner B; Yin Y
PLoS One; 2016; 11(5):e0156121. PubMed ID: 27224469
[TBL] [Abstract][Full Text] [Related]
16. Depression and recurrence of atrial fibrillation after catheter ablation: a meta-analysis of cohort studies.
Zhuo C; Ji F; Lin X; Jiang D; Wang L; Tian H; Xu Y; Liu S; Chen C
J Affect Disord; 2020 Jun; 271():27-32. PubMed ID: 32312694
[TBL] [Abstract][Full Text] [Related]
17. Reviewing the future of renin-angiotensin system blockade: the role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the prevention of atrial fibrillation.
Ducharme A; Schiffrin EL
Can J Cardiol; 2010 Dec; 26 Suppl E():21E-23E. PubMed ID: 21620287
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis.
Ma H; Jiang H; Feng J; Gan Y
Cardiovasc Ther; 2021; 2021():6628469. PubMed ID: 34104205
[TBL] [Abstract][Full Text] [Related]
19. Catheter ablation for paroxysmal and persistent atrial fibrillation.
Chen HS; Wen JM; Wu SN; Liu JP
Cochrane Database Syst Rev; 2012 Apr; (4):CD007101. PubMed ID: 22513945
[TBL] [Abstract][Full Text] [Related]
20. Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study).
Yamabe H; Kaikita K; Matsumura T; Iwasa A; Koyama J; Uemura T; Morikami Y; Tsunoda R; Morihisa K; Fujimoto K; Kajiwara I; Matsui K; Tsujita K; Ogawa H
J Cardiol; 2018 Feb; 71(2):129-134. PubMed ID: 28886992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
